Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spain

Showing results (71-80 of 1,493) with videos related to

Pageof 150
Sort By:
The Nurse Practitioner|September 21, 2020
Understanding the most commonly billed diagnoses in primary care: Headache disordersJulia Rogers, Scarlet Spain
Expert Opinion on Biological Therapy|January 12, 2016
Combination immune checkpoint blockade with ipilimumab and nivolumab in the management of advanced melanomaLavinia Spain, James Larkin
Occupational Health & Safety (Waco, Tex.)|January 1, 1987
Policies have been confusing, but asbestos awareness improves. Interview by Sheri Hagen PooreW Spain, D Mayer
Insights Into Imaging|June 12, 2025
Neuroimaging features of immune-related adverse events due to immune checkpoint inhibitor therapyArian Lasocki, Lavinia Spain
JAMA|May 16, 2019
Rib FracturesIoana Baiu, David Spain
Biotechnology and Bioengineering|April 1, 1999
Operation of mixed-culture immobilized cell reactors for the metabolism of meta- and para-nitrobenzoate by comamonas sp. JS46 and comamonas sp. JS47Goodall, Thomas, Spain, et al.
Immunotherapy|May 21, 2016
Weighing up the pros and cons of immune checkpoint inhibitors in the treatment of melanomaLavinia Spain, James Larkin
The Journal of the Oklahoma State Medical Association|August 1, 1989
5-Fluorouracil-induced anginaM Spain, D McPherson
International Journal of Spine Surgery|April 6, 2017
Surgical Revision after Sacroiliac Joint Fixation or FusionKatie Spain, Timothy Holt
Idrugs : the Investigational Drugs Journal|September 6, 2007
Key factors in evaluating potential clinical biomarkersMichael Spain, Ralph McDade
Pageof 150

Showing results (71-80 of 1,493) with videos related to

Sort By:
Pageof 150
The Nurse Practitioner|September 21, 2020
Understanding the most commonly billed diagnoses in primary care: Headache disordersJulia Rogers, Scarlet Spain
Expert Opinion on Biological Therapy|January 12, 2016
Combination immune checkpoint blockade with ipilimumab and nivolumab in the management of advanced melanomaLavinia Spain, James Larkin
Occupational Health & Safety (Waco, Tex.)|January 1, 1987
Policies have been confusing, but asbestos awareness improves. Interview by Sheri Hagen PooreW Spain, D Mayer
Insights Into Imaging|June 12, 2025
Neuroimaging features of immune-related adverse events due to immune checkpoint inhibitor therapyArian Lasocki, Lavinia Spain
JAMA|May 16, 2019
Rib FracturesIoana Baiu, David Spain
Biotechnology and Bioengineering|April 1, 1999
Operation of mixed-culture immobilized cell reactors for the metabolism of meta- and para-nitrobenzoate by comamonas sp. JS46 and comamonas sp. JS47Goodall, Thomas, Spain, et al.
Immunotherapy|May 21, 2016
Weighing up the pros and cons of immune checkpoint inhibitors in the treatment of melanomaLavinia Spain, James Larkin
The Journal of the Oklahoma State Medical Association|August 1, 1989
5-Fluorouracil-induced anginaM Spain, D McPherson
International Journal of Spine Surgery|April 6, 2017
Surgical Revision after Sacroiliac Joint Fixation or FusionKatie Spain, Timothy Holt
Idrugs : the Investigational Drugs Journal|September 6, 2007
Key factors in evaluating potential clinical biomarkersMichael Spain, Ralph McDade
Pageof 150